Assessing methylation status of PAX1 in cervical scrapings, as a novel diagnostic and predictive biomarker, was closely related to screen cervical cancer

International Journal of Clinical and Experimental Pathology

Volumn 8, Issue 2, 2015, Pages 1674-1681

  Xu, Jun ^a   Xu, Ling ^a   Yang, Baohua ^a   Wang, Lifeng ^a   Lin, Xiao ^a   Tu, Hong ^b  

^a The Central Hospital of Minhang District   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Bisulfate pyrosequencing; Cervical cancer; HPV; Methylation; PAX1

Indexed keywords

PAIRED BOX TRANSCRIPTION FACTOR; PAX1 TRANSCRIPTION FACTOR; TUMOR MARKER;

ADULT; AREA UNDER THE CURVE; CERVICAL INTRAEPITHELIAL NEOPLASIA; COMPLICATION; DNA METHYLATION; EARLY CANCER DIAGNOSIS; FEMALE; GENETICS; HUMAN; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; PROCEDURES; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; UTERINE CERVICAL NEOPLASMS; VAGINA SMEAR;

ADULT; AREA UNDER CURVE; BIOMARKERS, TUMOR; CERVICAL INTRAEPITHELIAL NEOPLASIA; DNA METHYLATION; EARLY DETECTION OF CANCER; FEMALE; HUMANS; PAIRED BOX TRANSCRIPTION FACTORS; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; ROC CURVE; SENSITIVITY AND SPECIFICITY; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 84928137373     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Ferlay J, Forman D, Mathers CD and Bray F. Breast and cervical cancer in 187 countries between 1980 and 2010. Lancet 2012; 379: 1390-1391.
2. Forouzanfar MH, Foreman KJ, Delossantos AM, Lozano R, Lopez AD, Murray CJ and Naghavi M. Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis. Lancet 2011; 378: 1461-1484.
3. Solomon D, Davey D, Kurman R, Moriarty A, O'Connor D, Prey M, Raab S, Sherman M, Wilbur D, Wright T Jr and Young N. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA 2002; 287: 2114-2119.
4. Wright TC Jr, Massad LS, Dunton CJ, Spitzer M, Wilkinson EJ and Solomon D. 2006 consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ. Am J Obstet Gynecol 2007; 197: 340-345.
5. McCredie MR, Sharples KJ, Paul C, Baranyai J, Medley G, Jones RW and Skegg DC. Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study. Lancet Oncol 2008; 9: 425-434.
6. Castle PE, Schiffman M, Wheeler CM and Solomon D. Evidence for frequent regression of cervical intraepithelial neoplasia-grade 2. Obstet Gynecol 2009; 113: 18-25.
7. Nessa A, Rashid MH, E-Ferdous N and Chowdhury A. Screening for and management of high-grade cervical intraepithelial neoplasia in Bangladesh: a cross-sectional study comparing two protocols. J Obstet Gynaecol Res 2013; 39: 564-571.
8. Kaufman RH, Adam E, Icenogle J, Lawson H, Lee N, Reeves KO, Irwin J, Simon T, Press M, Uhler R, Entman C and Reeves WC. Relevance of human papillomavirus screening in management of cervical intraepithelial neoplasia. Am J Obstet Gynecol 1997; 176: 87-92.
9. Dillner J, Rebolj M, Birembaut P, Petry KU, Szarewski A, Munk C, de Sanjose S, Naucler P, Lloveras B, Kjaer S, Cuzick J, van Ballegooijen M, Clavel C and Iftner T. Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study. BMJ 2008; 337: a1754.
10. Eide ML and Debaque H. HPV detection methods and genotyping techniques in screening for cervical cancer. Ann Pathol 2012; 32: e15-23, 401-409.
11. Zhang Y, Chen FQ, Sun YH, Zhou SY, Li TY and Chen R. Effects of DNMT1 silencing on malignant phenotype and methylated gene expression in cervical cancer cells. J Exp Clin Cancer Res 2011; 30: 98.
12. Suzuki H, Maruyama R, Yamamoto E and Kai M. Epigenetic alteration and microRNA dysregulation in cancer. Front Genet 2013; 4: 258.
13. Yang N, Eijsink JJ, Lendvai A, Volders HH, Klip H, Buikema HJ, van Hemel BM, Schuuring E, van der Zee AG and Wisman GB. Methylation markers for CCNA1 and C13ORF18 are strongly associated with high-grade cervical intraepithelial neoplasia and cervical cancer in cervical scrapings. Cancer Epidemiol Biomarkers Prev 2009; 18: 3000-3007.
14. Kim JH, Choi YD, Lee JS, Lee JH, Nam JH and Choi C. Assessment of DNA methylation for the detection of cervical neoplasia in liquid-based cytology specimens. Gynecol Oncol 2010; 116: 99-104.
15. Chang CC, Huang RL, Wang HC, Liao YP, Yu MH and Lai HC. High methylation rate of LMX1A, NKX6-1, PAX1, PTPRR, SOX1, and ZNF582 genes in cervical adenocarcinoma. Int J Gynecol Cancer 2014; 24: 201-209.
16. McGaughran JM, Oates A, Donnai D, Read AP and Tassabehji M. Mutations in PAX1 may be associated with Klippel-Feil syndrome. Eur J Hum Genet 2003; 11: 468-474.
17. Lai HC, Lin YW, Huang TH, Yan P, Huang RL, Wang HC, Liu J, Chan MW, Chu TY, Sun CA, Chang CC and Yu MH. Identification of novel DNA methylation markers in cervical cancer. Int J Cancer 2008; 123: 161-167.
18. Su HY, Lai HC, Lin YW, Chou YC, Liu CY and Yu MH. An epigenetic marker panel for screening and prognostic prediction of ovarian cancer. Int J Cancer 2009; 124: 387-393.
19. Huang TH, Lai HC, Liu HW, Lin CJ, Wang KH, Ding DC and Chu TY. Quantitative analysis of methylation status of the PAX1 gene for detection of cervical cancer. Int J Gynecol Cancer 2010; 20: 513-519.
20. Wang ZM. PAX1 methylation analysis by MS-HRM is useful in triage of high-grade squamous intraepithelial lesions. Asian Pac J Cancer Prev 2014; 15: 891-894.
21. Fabrizii M, Moinfar F, Jelinek HF, Karperien A and Ahammer H. Fractal analysis of cervical intraepithelial neoplasia. PLoS One 2014; 9: e108457.
22. Rakotomahenina H, Garrigue I, Marty M and Brun JL. [Prevention and screening of cervical cancer]. Rev Prat 2014; 64: 780-785.
23. Bosch FX, Lorincz A, Munoz N, Meijer CJ and Shah KV. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 2002; 55: 244-265.
24. Herman JG and Baylin SB. Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med 2003; 349: 2042-2054.
25. Owens CL, Buist DS, Peterson D, Kamineni A, Weinmann S, Ross T, Williams AE, Stark A, Adams KF, Doubeni CA and Field TS. Follow-up and clinical significance of unsatisfactory liquid-based Papanicolaou tests. Cancer Cytopathol 2014.
26. Tjalma WA and Depuydt CE. Cervical atypical glandular cells and false negative HPV testing: a dramatic reality of the wrong test at the right place. Eur J Gynaecol Oncol 2014; 35: 117-120.
27. Steenbergen RD, Ongenaert M, Snellenberg S, Trooskens G, van der Meide WF, Pandey D, Bloushtain-Qimron N, Polyak K, Meijer CJ, Snijders PJ and Van Criekinge W. Methylation-specific digital karyotyping of HPV16E6E7-expressing human keratinocytes identifies novel methylation events in cervical carcinogenesis. J Pathol 2013; 231: 53-62.